Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

175.12
-0.8000-0.45%
Post-market: 175.120.00000.00%19:53 EDT
Volume:1.52M
Turnover:268.05M
Market Cap:8.96B
PE:875.60
High:181.44
Open:173.78
Low:173.78
Close:175.92
Loading ...

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 Jan

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
29 Jan

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call

Business Wire
·
29 Jan

Charles River price target lowered to $195 from $210 at BofA

TIPRANKS
·
28 Jan

Bank of America Securities Sticks to Its Hold Rating for Charles River Labs (CRL)

TIPRANKS
·
27 Jan

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
25 Jan

Charles River Labs Is Maintained at Buy by Goldman Sachs

Dow Jones
·
24 Jan

Goldman Sachs Adjusts Charles River Laboratories International Price Target to $190 From $220, Maintains Buy Rating

MT Newswires Live
·
23 Jan

BCA projects higher construction demand for 2025; SGX listcos to look out for

Felicia Tan
·
23 Jan

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises

Zacks
·
22 Jan

William Blair Downgrades Charles River Laboratories International to Market Perform From Outperform

MT Newswires Live
·
22 Jan

Charles River Labs Cut to Market Perform From Outperform by William Blair

Dow Jones
·
22 Jan

Charles River downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
22 Jan

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Jan

FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs

Benzinga
·
22 Jan

FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression

Benzinga
·
22 Jan